ev3 Inc. Accepts Resignation of Dr. John Simpson

PLYMOUTH, Minn., Feb 08, 2008 /PRNewswire-FirstCall via COMTEX/ -- ev3 Inc. (Nasdaq: EVVV), a global endovascular device company, today announced the resignation of Dr. John Simpson from his position as Chief Scientist and from the company's board of directors effective February 7, 2008.
"Over the last thirty years, few people have shaped the treatment of cardiovascular disease as much as Dr. John Simpson with his numerous inventions and vision for improving the lives of patients worldwide," said Jim Corbett, chairman, president and chief executive officer of ev3 Inc. "He leaves a legacy of innovation and a foundation on which we intend to build in our effort to improve patient treatment."

full article >> http://www.foxbusiness.com/markets/industries/health-care/article/ev3-accepts-resignation-dr-john-simpson_472442_10.html